2025年全球基因型鑒定檢測市場報告

預計未來幾年基因型鑒定檢測市場規模將呈指數級成長，到2029年將達到946.1億美元，複合年成長率為23.0%。預測期內的成長歸因於客製化和個人化、健康保健趨勢、電子商務的成長、智慧功能性玻璃器皿以及烹飪和調酒術趨勢。預測期內的主要趨勢包括材料創新、創新形狀和設計、智慧玻璃、特殊飲水杯以及健康和安全功能。

未來五年預測成長率為23.0%，較先前的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。預計關稅壁壘將阻礙美國市場的發展，增加來自韓國和英國的SNP微陣列晶片和多態性陣列（PCR）試劑的成本，減緩個人化醫療的應用，並增加分子診斷實驗室的支出。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，其影響也可能更為廣泛。

遺傳疾病的日益普及預計將推動基因型鑒定檢測市場的成長。遺傳疾病是由個體DNA的異常或突變引起的。基因型鑒定檢測在識別和分析這些基因變異方面發揮關鍵作用，能夠檢測與特定遺傳疾病相關的特定突變或變異。例如，英國慈善機構Gene People在2023年6月報告稱，英國約每25名兒童中就有1名患有遺傳疾病，每年約有3萬名新生兒和嬰兒以及超過240萬名兒童和成人受到影響。因此，遺傳疾病的日益普及是推動基因型鑒定檢測市場擴張的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球基因型鑒定分析：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 最終用途產業分析
• 全球基因型鑒定檢測市場：成長率分析
• 全球基因型鑒定檢測市場表現：規模與成長，2019-2024
• 全球基因型鑒定檢測市場預測：規模與成長，2024-2029年，2034年
• 全球基因型鑒定檢測：總潛在市場（TAM）

第6章 市場細分

• 全球基因型鑒定檢測市場（依產品及服務分類）、實際規模及預測（2019-2024 年、2024-2029 年及 2034 年）
• 試劑和套件
• 基因型鑒定服務
• 裝置
• 生物資訊學
• 全球基因型鑒定檢測市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 微陣列
• 聚合酵素鏈鎖反應
• 定序
• 毛細管電泳
• 基質輔助雷射解吸或電離飛行時間質譜法
• 其他技術
• 全球基因型鑒定檢測市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 藥物基因組學
• 個性化醫療和診斷
• 動物遺傳學
• 農業生物技術
• 研究和診斷實驗室
• 學術機構
• 全球基因型鑒定檢測市場：按試劑和套件（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
• DNA萃取試劑套件
• PCR試劑
• SNP基因型鑒定套件
• 基因型鑒定服務
• PCR基因分型
• 全基因組定序服務
• SNP基因型鑒定服務
• 全球基因型鑒定檢測市場：依儀器類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
• PCR儀
• 定序設備
• 微陣列
• 全球基因型鑒定檢測市場：依生物資訊類型細分，實際狀況及預測，2019-2024 年、2024-2029 年、2034 年
• 數據分析軟體
• 基因型鑒定資料管理工具

第7章 區域和國家分析

• 全球基因型鑒定檢測市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球基因型鑒定檢測市場：依國家分類、實際規模及預測（2019-2024 年、2024-2029 年預測、2034 年預測）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 基因型鑒定檢測市場：競爭格局
• 基因型鑒定檢測市場：公司簡介
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• PerkinElmer Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Qiagen NV
• BGI Genomics
• LGC Biosearch Technologies
• GenScript Biotech
• Inotiv Inc.
• Promega Corporation
• Luminex Corporation
• Integrated DNA Technologies Inc.
• Oxford Nanopore Technologies plc
• Sequenom Inc.
• 23andMe Inc.
• Novogene Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029年基因型鑒定檢測市場：提供新機會的國家
• 2029年基因型鑒定檢測市場：細分領域帶來新機會
• 2029年基因型鑒定檢測市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

A genotyping assay is a laboratory technique or method employed to determine an individual's genetic makeup at specific genetic loci or positions within their DNA. It involves the identification and analysis of genetic variations, such as single nucleotide polymorphisms (SNPs) or insertions and deletions, present in an individual's genome.

The primary products and services in the genotyping assay market include reagents and kits, genotyping services, instruments, and bioinformatics. Reagents and kits serve as crucial components in various scientific and laboratory processes, especially in fields such as molecular biology, chemistry, and diagnostics. Various technologies are employed in genotyping assays, including microarrays, polymerase chain reaction, sequencing, capillary electrophoresis, matrix-assisted laser desorption or ionization-time of flight mass spectrometry, and others. These technologies cater to diverse end-users such as pharmacogenomics, personalized medicine and diagnostics, animal genetics, agricultural biotechnology, research and diagnostic laboratories, and academic institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The genotyping assay market research report is one of a series of new reports from The Business Research Company that provides genotyping assay market statistics, including genotyping assay industry global market size, regional shares, competitors with a genotyping assay market share, detailed genotyping assay market segments, market trends and opportunities, and any further data you may need to thrive in the genotyping assay industry. This genotyping assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genotyping assay market size has grown exponentially in recent years. It will grow from $33.98 billion in 2024 to $41.31 billion in 2025 at a compound annual growth rate (CAGR) of 21.6%. The growth in the historic period can be attributed to traditional glassware usage, cultural and lifestyle influences, economic factors, hospitality and foodservice industry growth, gift and decor trends.

The genotyping assay market size is expected to see exponential growth in the next few years. It will grow to $94.61 billion in 2029 at a compound annual growth rate (CAGR) of 23.0%. The growth in the forecast period can be attributed to customization and personalization, health and wellness trends, e-commerce growth, smart and functional glassware, culinary and mixology trends. Major trends in the forecast period include material innovation, innovative shapes and designs, smart glassware, specialized glassware for beverages, health and safety features.

The forecast of 23.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of SNP microarray chips and polymorphism arrays(PCR) reagents sourced from South Korea and the UK, thereby delaying personalized medicine applications and elevating molecular diagnostics lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of genetic disorders is expected to drive the growth of the genotyping assay market. Genetic disorders result from abnormalities or mutations in an individual's DNA. Genotyping assays play a crucial role in identifying and analyzing these genetic variations, enabling the detection of specific mutations or variations associated with particular genetic disorders. For example, Gene People, a UK-based charity organization, reported in June 2023 that approximately one in every 25 children in the UK had a genetic disorder, affecting around 30,000 newborns and young children annually, along with more than 2.4 million children and adults. Hence, the growing prevalence of genetic disorders is a significant factor contributing to the expansion of the genotyping assay market.

The rising demand for personalized medicine is another key driver for the growth of the genotyping assay market. Personalized medicine involves tailoring medical treatment to an individual's unique genetic makeup, offering more precise and effective healthcare interventions. Genotyping assays are essential in personalized medicine to analyze an individual's genetic profile, enabling customized drug selection and dosage. In January 2023, the Food and Drug Administration (FDA) reported that out of the 35 therapeutic new molecular entities (NMEs) approved in 2022, approximately 34% (12 of them) were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This highlights the increasing demand for personalized medicine, which, in turn, is propelling the growth of the genotyping assay market.

Key players in the genotyping assay market are actively advancing genomic research, such as the development of CE-IVD marked assays to detect treatment-resistant strains of HIV-1. An example is the CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit by Thermo Fisher Scientific, launched in January 2023. This Sanger sequencing-based assay examines HIV-positive samples to identify genetic variants resistant to common antiretroviral therapeutics. The kit's unique features include assessing genomic mutations, utilizing HIV RNA, detecting drug resistance mutations through gold-standard Sanger sequencing technology, and being designed for clinical use. This product launch adds value by enhancing the detection of treatment-resistant HIV-1 strains, providing ready-to-use reagents and controls, meeting regulatory requirements, exhibiting high-performance characteristics, and being compatible with existing sequencing platforms and workflows.

In August 2023, Transnetyx Inc., a US-based biotechnology company, acquired Laragen Inc. for an undisclosed sum. Through this acquisition, Transnetyx aims to broaden its solutions by incorporating sequencing and next-generation sequencing (NGS) services, offering large research institutes improved access to cutting-edge genetic services. Laragen Inc., also based in the US, specializes in providing sequencing and genotyping assay services for DNA.

Major companies operating in the genotyping assay market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Danaher Corporation, Eurofins Scientific SE, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, BGI Genomics, LGC Biosearch Technologies, GenScript Biotech, Inotiv Inc., Promega Corporation, Luminex Corporation, Integrated DNA Technologies Inc., Integrated DNA Technologies Ltd., Sequenom Inc., 23andMe Inc., Novogene Corporation, Oxford Nanopore Technologies PLC, GenMark Diagnostics Inc., Macrogen Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Genewiz Inc., New England Biolabs, TrimGen Corporation, Xcelris Genomics

North America was the largest region in the genotyping assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genotyping assay market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genotyping assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genotyping assay market includes revenues earned by entities that provide genotyping assay services such as single nucleotide polymorphisms (SNPs) genotyping, short tandem repeats (STRs) genotyping, whole genome genotyping, and clinical genotyping services. The market value includes the value of related goods sold by the service provider or included within the service offering. The genotyping assay market consists of sales of products such as polymerase chain reaction (PCR) primers, SNP genotyping kits, DNA extraction kits, and microarray chips. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genotyping Assay Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genotyping assay market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genotyping assay ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genotyping assay market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product And Service: Reagents And Kits; Genotyping Services; Instruments; Bioinformatics
• 2) By Technology: Microarrays; Polymerase Chain Reaction; Sequencing; Capillary Electrophoresis; Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry; Other Technologies
• 3) By End-User: Pharmacogenomics; Personalized Medicine And Diagnostics; Animal Genetics; Agricultural Biotechnology; Research And Diagnostic Laboratories; Academic Institutes
• Subsegments:
• 1) By Reagents And Kits: DNA Extraction Kits; PCR Reagents; SNP Genotyping Kits; Genotyping Services; Genotyping by PCR; Whole Genome Sequencing Services; SNP Genotyping Services
• 2) By Instruments: PCR Machines; Sequencing Instruments; Microarrays
• 3) By Bioinformatics: Data Analysis Software; Genotyping Data Management Tools
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; Danaher Corporation; Eurofins Scientific SE; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; Qiagen NV; BGI Genomics; LGC Biosearch Technologies; GenScript Biotech; Inotiv Inc.; Promega Corporation; Luminex Corporation; Integrated DNA Technologies Inc.; Integrated DNA Technologies Ltd.; Sequenom Inc.; 23andMe Inc.; Novogene Corporation; Oxford Nanopore Technologies plc; GenMark Diagnostics Inc.; Macrogen Inc.; Pacific Biosciences of California Inc.; Standard BioTools Inc.; Genewiz Inc.; New England Biolabs; TrimGen Corporation; Xcelris Genomics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genotyping Assay Market Characteristics

3. Genotyping Assay Market Trends And Strategies

4. Genotyping Assay Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Genotyping Assay Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genotyping Assay PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genotyping Assay Market Growth Rate Analysis
• 5.4. Global Genotyping Assay Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genotyping Assay Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genotyping Assay Total Addressable Market (TAM)

6. Genotyping Assay Market Segmentation

• 6.1. Global Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Kits
• Genotyping Services
• Instruments
• Bioinformatics
• 6.2. Global Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microarrays
• Polymerase Chain Reaction
• Sequencing
• Capillary Electrophoresis
• Matrix-assisted Laser Desorption Or Ionization-Time Of Flight Mass Spectrometry
• Other Technologies
• 6.3. Global Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacogenomics
• Personalized Medicine And Diagnostics
• Animal Genetics
• Agricultural Biotechnology
• Research And Diagnostic Laboratories
• Academic Institutes
• 6.4. Global Genotyping Assay Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Extraction Kits
• PCR Reagents
• SNP Genotyping Kits
• Genotyping Services
• Genotyping by PCR
• Whole Genome Sequencing Services
• SNP Genotyping Services
• 6.5. Global Genotyping Assay Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Machines
• Sequencing Instruments
• Microarrays
• 6.6. Global Genotyping Assay Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Data Analysis Software
• Genotyping Data Management Tools

7. Genotyping Assay Market Regional And Country Analysis

• 7.1. Global Genotyping Assay Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genotyping Assay Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genotyping Assay Market

• 8.1. Asia-Pacific Genotyping Assay Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genotyping Assay Market

• 9.1. China Genotyping Assay Market Overview
• 9.2. China Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genotyping Assay Market

• 10.1. India Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genotyping Assay Market

• 11.1. Japan Genotyping Assay Market Overview
• 11.2. Japan Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genotyping Assay Market

• 12.1. Australia Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genotyping Assay Market

• 13.1. Indonesia Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genotyping Assay Market

• 14.1. South Korea Genotyping Assay Market Overview
• 14.2. South Korea Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genotyping Assay Market

• 15.1. Western Europe Genotyping Assay Market Overview
• 15.2. Western Europe Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genotyping Assay Market

• 16.1. UK Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genotyping Assay Market

• 17.1. Germany Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genotyping Assay Market

• 18.1. France Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genotyping Assay Market

• 19.1. Italy Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genotyping Assay Market

• 20.1. Spain Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genotyping Assay Market

• 21.1. Eastern Europe Genotyping Assay Market Overview
• 21.2. Eastern Europe Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genotyping Assay Market

• 22.1. Russia Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genotyping Assay Market

• 23.1. North America Genotyping Assay Market Overview
• 23.2. North America Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genotyping Assay Market

• 24.1. USA Genotyping Assay Market Overview
• 24.2. USA Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genotyping Assay Market

• 25.1. Canada Genotyping Assay Market Overview
• 25.2. Canada Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genotyping Assay Market

• 26.1. South America Genotyping Assay Market Overview
• 26.2. South America Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genotyping Assay Market

• 27.1. Brazil Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genotyping Assay Market

• 28.1. Middle East Genotyping Assay Market Overview
• 28.2. Middle East Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genotyping Assay Market

• 29.1. Africa Genotyping Assay Market Overview
• 29.2. Africa Genotyping Assay Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genotyping Assay Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genotyping Assay Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genotyping Assay Market Competitive Landscape And Company Profiles

• 30.1. Genotyping Assay Market Competitive Landscape
• 30.2. Genotyping Assay Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genotyping Assay Market Other Major And Innovative Companies

• 31.1. PerkinElmer Inc.
• 31.2. Illumina Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Qiagen NV
• 31.5. BGI Genomics
• 31.6. LGC Biosearch Technologies
• 31.7. GenScript Biotech
• 31.8. Inotiv Inc.
• 31.9. Promega Corporation
• 31.10. Luminex Corporation
• 31.11. Integrated DNA Technologies Inc.
• 31.12. Oxford Nanopore Technologies plc
• 31.13. Sequenom Inc.
• 31.14. 23andMe Inc.
• 31.15. Novogene Corporation

32. Global Genotyping Assay Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genotyping Assay Market

34. Recent Developments In The Genotyping Assay Market

35. Genotyping Assay Market High Potential Countries, Segments and Strategies

• 35.1 Genotyping Assay Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genotyping Assay Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genotyping Assay Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer